Zhou et al. found in 2016 that transcription levels of GPR160 in prostate cancer tissue samples and cell lines were significantly higher than in normal prostate tissue and cells (Zhou et al., 2016). This evidence concerns the gene GPR160 and Familial prostate cancer.